Equillium, Inc.EQNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank12
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P12
Within normal range
vs 5Y Ago
-5.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-25.26%
Q3 202551.33%
Q2 2025-27.19%
Q1 202565.97%
Q4 2024-45.85%
Q3 20244.23%
Q2 2024-15.11%
Q1 202415.96%
Q4 2023-9.21%
Q3 202314.48%
Q2 2023-17.25%
Q1 2023-28.45%
Q4 202216.26%
Q3 20229.89%
Q2 202215.55%
Q1 202223.93%
Q4 2021-2.00%
Q3 20211.33%
Q2 20211.53%
Q1 202117.15%
Q4 20204.57%
Q3 2020-15.42%
Q2 2020-1.06%
Q1 202027.07%
Q4 20190.89%
Q3 2019-2.15%
Q2 2019-15.45%
Q1 201951.40%
Q4 201870.39%
Q3 201871.55%
Q2 201856.42%
Q1 2018137.62%
Q4 2017366.18%
Q3 2017-81.96%
Q2 20170.00%